商品分類

瀏覽歷史

B21515	異補(bǔ)骨脂素
源葉	分析標(biāo)準(zhǔn)品,HPLC≥98%

英文名：
Isopsoralen

別名：

CAS號(hào)：
523-50-2

分子式：
C₁₁H₆O₃

分子量：
186.167

MDL：
MFCD00064930

核磁/質(zhì)譜：

品牌	貨號(hào)	產(chǎn)品規(guī)格	價(jià)格(RMB)	庫存（上海）	北京	武漢	南京	數(shù)量	計(jì)量單位	加入購物車...
源葉	B21515-20mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥180.00元	>10	2	7	1		EA	加入購物車
源葉	B21515-200mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥1080.00元	>10	-	-	3		EA	加入購物車

大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》，到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)(23篇)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

熔點(diǎn)： 132-134°C

沸點(diǎn)： 362.6 °C at 760 mmHg

外觀：無色結(jié)晶

溶解性： DMSO：25mg/ml

敏感性：對(duì)熱敏感

儲(chǔ)存條件： 2-8℃

注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

23. [2.8] Zhu Yuanying et al."New insight into the molecular mechanism of TCM Bufei Huoxue formula for chronic obstructive pulmonary disease based on network pharmacology and experimental verification."JOURNAL OF PHARMACY AND PHARMACOLOGY.2024 Aug;:

22. [IF=4.1] Liang-Min Chen et al."Psoralen and Isopsoralen, Two Estrogen-Like Natural Products from Psoraleae Fructus, Induced Cholestasis via Activation of ERK1/2."CHEMICAL RESEARCH IN TOXICOLOGY".2024;XXXX(XXX):XXX-XXX

21. [IF=4.6] Shang Huiying et al."Exploring the mechanism and phytochemicals in Psoraleae Fructus-induced hepatotoxicity based on RNA-seq, in vitro screening and molecular docking."Scientific Reports.2024 Jan;14(1):1-15

20. [IF=5.4] Hui Ren et al."Integrated serum metabolomics and network pharmacology analysis on the bioactive metabolites and mechanism exploration of Bufei huoxue capsule on chronic obstructive pulmonary disease rats."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;324:117816

19. [IF=3.571] Yuhao Zhang et al."A novel strategy integrating gas phase fractionation with staggered mass range and LC-MS/MS molecular network for comprehensive metabolites profiling of Gui Ling Ji in rats."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2023 Jan;222

18. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950

17. [IF=5.455] Zhang Xian et al."Neurobehavioral alternations of the female offspring born to polycystic ovary syndrome model rats administered by Chinese herbal medicine."Chin Med-Uk. 2021 Dec;16(1):1-19

16. [IF=1.908] Dan Lu et al."Mechanism-based inactivation of cytochrome P450 2B6 by isopsoralen."Xenobiotica. 2016;46(4):335-341

15. [IF=2.675] Xiumin Chen et al."Isobavachalcone and bavachinin from Psoraleae Fructus modulate Aβ42 aggregation process through different mechanisms in vitro."Febs Lett. 2013 Sep;587(18):2930-2935

14. [IF=4.411] Li Jia et al."Systematic Profiling of the Multicomponents and Authentication of Erzhi Pill by UHPLC/Q-Orbitrap-MS Oriented Rapid Polarity-Switching Data-Dependent Acquisition and Selective Monitoring of the Chemical Markers Deduced from Fingerprint Analys

13. Chen, Xiumin, Yanfang Yang, and Yingtao Zhang. "Isobavachalcone and bavachinin from Psoraleae Fructus modulate Aβ42 aggregation process through different mechanisms in vitro."?Febs Letters?587.18 (2013): 2930-2935.https://doi.org/10.1016/j.febslet.2013.07.

12. Chen, Zhi-Jing, et al. "Dietary total prenylflavonoids from the fruits of Psoralea corylifolia L. prevents age-related cognitive deficits and down-regulates Alzheimer’s markers in SAMP8 mice." Molecules 23.1 (2018): 196.https://doi.org/10.3390/molecules230

11. 李佳妍,劉欣欣,寧青,李彥東,石子琪,韋英杰.基于斑馬魚模型的補(bǔ)骨脂毒性相關(guān)成分群的高效辨識(shí)研究[J].中草藥,2021,52(01):129-136.

10. 王雪蓮, 李敏敏, 胡軍華,等. 18種香豆素類化合物對(duì)柑桔炭疽菌的抑制作用[J]. 中國南方果樹, 2013, 42(004):73-74.

9. 黃婷, 郭晏華, 丁黎艷,等. 藥汁制補(bǔ)骨脂對(duì)其抗OP化學(xué)成分影響[J]. 遼寧中醫(yī)藥大學(xué)學(xué)報(bào), 2013(05):62-64.

8. 丁黎艷周璐王麗娜等. 一測(cè)多評(píng)法測(cè)定補(bǔ)骨脂中不同類型成分的含量[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志 2013 19(5):152-154.

7. 鄭楠, 郭晏華, 劉刈,等. 補(bǔ)骨脂不同炮制品的指紋圖譜研究[J]. 遼寧中醫(yī)雜志, 2015(04):157-159.

6. 曹淑麗趙春杰蔡麗俠荊敏琪李一白.UPLC法同時(shí)測(cè)定參苓白術(shù)散中補(bǔ)骨脂素、異補(bǔ)骨脂素、白術(shù)內(nèi)酯Ⅲ和異歐前胡素的含量[J].沈陽藥科大學(xué)學(xué)報(bào) 2018 35(07):568-573.

5. 丁玉婷鄭竹宏趙仁云等. UPLC-Q-TOF-MS~E技術(shù)結(jié)合UNIFI篩查平臺(tái)快速分析補(bǔ)骨脂化學(xué)成分[J]. 質(zhì)譜學(xué)報(bào) 2018.

4. 張娜, 劉傳鑫, 張晨寧,等. 結(jié)合UPLC-QTOF-MS和網(wǎng)絡(luò)毒理學(xué)技術(shù)初探補(bǔ)骨脂致肝毒性機(jī)制[J]. 國際藥學(xué)研究雜志 2020年47卷5期, 370-376頁, ISTIC PKU CSCD, 2020.

3. 宣仙君, 毛紅嬌, 宋冰潔,等. 異補(bǔ)骨脂素對(duì)磷酸三鈣顆粒誘導(dǎo)骨溶解抑制作用[J]. 營養(yǎng)學(xué)報(bào), 2016, 38(003):273-277.

2. 范冰冰, 郭晏華, 黃婷. 基于組織分布學(xué)特征評(píng)價(jià)補(bǔ)骨脂炮制工藝研究[J]. 遼寧中醫(yī)藥大學(xué)學(xué)報(bào), 2019, 21(02):58-60.

1. 楊潔芳.LC-MS法同時(shí)測(cè)定骨康膠囊中6種主要成分的含量[J].中國藥房 2012 23(35):3344-3346.